Bart Walker, Co-chair of the Healthcare & Life Sciences Industry Team, concentrates on mergers, acquisitions, and healthcare regulatory compliance. His practice includes advising healthcare providers as well as equity sponsors and lenders to the healthcare industry. In connection with representing healthcare providers, he works with hospitals, ambulatory surgery centers, dental services organizations (DSOs), urgent care providers, large physician group practices, end-stage renal disease facilities, and home health and DME companies on various regulatory and transactional matters.
He has represented lenders, borrowers and equity sponsors in various healthcare-related financing and acquisition transactions, including asset-based lending, mezzanine and senior credit facilities, and leveraged finance. He has assisted in the re-syndication and start-up of numerous ambulatory surgery centers and hospital-physician joint ventures. He regularly lectures and writes on transactional and regulatory issues affecting a wide range of healthcare businesses.
While earning his law degree from the University of Notre Dame, Bart was named a White Scholar of the Thomas J. White Center on Law and Government. As an undergraduate, he was named a Morehead Scholar at the University of North Carolina at Chapel Hill.
"…incredibly responsive … Bart’s knowledge and experience in the health care space ranging from representing healthcare systems, providers and private equity firms brings a unique value and perspective. He also is able to maintain calm in very contentious negotiations…" – Legal 500, 2022
"… Approachable, willingness to develop solutions to meet the needs of clients, and supports associates to demonstrate their individual skills/expertise without grandstanding." – Legal 500, 2022
Representation of a private equity fund in the multi-million dollar acquisition of an administrative services provider to a multi-site ophthalmology practice in New York.
Represented multiple tax-exempt health systems in connection with affiliation and sale transactions.
Represented large dermatology practice in formation of physician management services organization with private equity sponsor.
Represented private equity-backed dental services organization in multi-practice roll up.
Represented dental services organization in connection with initial formation and structuring, including establishment of dental practice and de novo clinical sites.
Represented nationwide clinical pathology lab business in growth recapitalization transaction with private equity fund.
Represented strategic acquirer in acquisition of majority interest in ambulatory surgery center.
Represented physician-owned ambulatory surgery center in sale to national strategic acquirer.
Negotiated tri-party joint venture surgery center among major health system, management company, and physician members.
Negotiated de novo surgery center joint venture between large hospital system and major orthopedic physician practice.
Represented a private equity fund in diligence and acquisition of one of the largest ASC chains in the country.
Represented a private equity fund in the acquisition of a multisite durable medical equipment provider.
Conducted regulatory and compliance diligence and transaction services on the acquisition of a medical device and pharmaceutical distributor, including change of ownership issues in 40 states.
Advised hospital on compliance with Stark, anti-kickback, and tax-exempt laws in the development of compensation arrangements for various physician services.
Represented nationwide provider of dialysis services in multi-facility dialysis facility acquisition.
Represented lead agent in healthcare regulatory aspects of syndicated credit facility to national provider of healthcare services.
Advised parties in structuring off-campus, provider-based facility.
Member, American Health Lawyers Association
Member, North Carolina Society of Healthcare Attorneys
Former Chairman, Board of Directors, NC MedAssist
Former Chairman, Board of Directors, Charlotte Chamber of Commerce Health Services Council
September 10, 2009
The rules of professional conduct in some jurisdictions require disclosure of selection methodology for certain public accolades and recognitions. Click here to view available selection methodologies.
Selected for inclusion in “Legal 500 United States,” Healthcare: Advice to Service Providers, 2021, 2022
Selected for inclusion as a "Leading Lawyer" in Regulatory & Litigation, 2018, 2019; in Healthcare, 2020-2022, Chambers USA
Selected for inclusion in The Best Lawyers in America, Health Care Law, Woodward/White, Inc., 2017-2022
Named "Lawyer of the Year," Health Care Law, Charlotte, The Best Lawyers, 2021
Named to "North Carolina Rising Stars," Health Care, Super Lawyers, Thomson Reuters, 2010-2019
Selected as an “Emerging Leader,” The M&A Advisor, 2017
Selected for inclusion as a "Leading Lawyer," Healthcare: Service Providers, North Carolina, Legal 500 US, 2017
Named "Up and Coming" in America's Leading Lawyers for Business, Healthcare, North Carolina, Chambers USA, 2017
D CEO Recognizes McGuireWoods for Advising Clients in Top M&A Deals of 2021
March 17, 2022
McGuireWoods Attorneys Recognized in 2022 Edition of The Best Lawyers in America
August 19, 2021
McGuireWoods Achieves Top Rankings in Chambers USA’s 2021 Leading Lawyers Guide
May 21, 2021
192 McGuireWoods Attorneys Recognized in 2021 Edition of The Best Lawyers in America
August 26, 2020